Genpharmasec

{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.02",
    "chg": -0.02,
    "chgp": "-1.92%",
    "dir": -1,
    "prev_price": "1.04",
    "mcapval": "58.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "11:13 AM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "2.31 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4096387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GenpharmasecLtd_mojoScore_4096387.png",
        "date": "2026-07-10 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4076970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GenpharmasecLtd_mojoScore_4076970.png",
        "date": "2026-06-29 10:10:05",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4058908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GenpharmasecLtd_mojoScore_4058908.png",
        "date": "2026-06-17 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4019945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GenpharmasecLtd_mojoScore_4019945.png",
        "date": "2026-05-29 10:10:42",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Are Genpharmasec Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-genpharmasec-ltd-latest-results-good-or-bad-4006935",
        "imagepath": "",
        "date": "2026-05-22 19:21:06",
        "description": "Genpharmasec Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company achieved a record net sales figure of ₹55.43 crores, reflecting a substantial year-on-year growth of 295.65% from ₹14.01 crores in Q4 FY25 and a sequential increase of 39.17% from the previous quarter. This growth indicates successful expansion in its trading and distribution segment.\n\nHowever, the profitability aspect raises concerns. The consolidated net profit for the quarter was ₹1.23 crores, which represents a significant year-on-year decline of 555.56%. The operating profit margin, excluding other income, was recorded at 3.61%, an improvement from the negative margin of -7.14% in the same quarter last year, but still below the 7.81% margin achieved in the previous quarter. This suggests that while sales have surged, the company struggles to convert this revenue into sustainable ope..."
      },
      {
        "title": "Genpharmasec Q4 FY26: Strong Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/genpharmasec-q4-fy26-strong-revenue-surge-masks-profitability-concerns-4005365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/Genpharmasec_quaterlyResult_4005365.png",
        "date": "2026-05-22 10:03:07",
        "description": "Genpharmasec Limited, a micro-cap trading and distribution company with a market capitalisation of ₹68.00 crores, reported its fourth quarter results for FY26 (Mar'26) with a consolidated net profit of ₹1.23 crores, representing a dramatic decline of 555.56% year-on-year from a loss of ₹0.27 crores in Mar'25. Despite impressive top-line expansion with revenues surging 295.65% YoY to ₹55.43 crores, the company continues to grapple with profitability challenges and structural concerns that have kept its stock under pressure, currently trading at ₹1.22 after a modest 4.27% gain on result day."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3996809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GenpharmasecLtd_mojoScore_3996809.png",
        "date": "2026-05-18 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3975837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GenpharmasecLtd_mojoScore_3975837.png",
        "date": "2026-05-05 10:10:02",
        "description": "Genpharmasec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3960705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3960705.png",
        "date": "2026-04-24 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      }
    ],
    "total": 5435,
    "sid": "329838",
    "stock_news_url": "https://www.marketsmojo.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Genpharmasec Ltd is Rated Strong Sell

2026-07-10 10:10:04

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-06-29 10:10:05

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-06-17 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-05-29 10:10:42

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Are Genpharmasec Ltd latest results good or bad?

2026-05-22 19:21:06

Genpharmasec Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company achieved a record net sales figure of ₹55.43 crores, reflecting a substantial year-on-year growth of 295.65% from ₹14.01 crores in Q4 FY25 and a sequential increase of 39.17% from the previous quarter. This growth indicates successful expansion in its trading and distribution segment. However, the profitability aspect raises concerns. The consolidated net profit for the quarter was ₹1.23 crores, which represents a significant year-on-year decline of 555.56%. The operating profit margin, excluding other income, was recorded at 3.61%, an improvement from the negative margin of -7.14% in the same quarter last year, but still below the 7.81% margin achieved in the previous quarter. This suggests that while sales have surged, the company struggles to convert this revenue into sustainable ope...

Read full news article

Genpharmasec Q4 FY26: Strong Revenue Surge Masks Profitability Concerns

2026-05-22 10:03:07

Genpharmasec Limited, a micro-cap trading and distribution company with a market capitalisation of ₹68.00 crores, reported its fourth quarter results for FY26 (Mar'26) with a consolidated net profit of ₹1.23 crores, representing a dramatic decline of 555.56% year-on-year from a loss of ₹0.27 crores in Mar'25. Despite impressive top-line expansion with revenues surging 295.65% YoY to ₹55.43 crores, the company continues to grapple with profitability challenges and structural concerns that have kept its stock under pressure, currently trading at ₹1.22 after a modest 4.27% gain on result day.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-05-18 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-05-05 10:10:02

Genpharmasec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-04-24 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

View All News